10.1371/journal.pone.0025324 115 DingK.LiuC.LiL.YangM.JiangN.LuoS.et al (2023)
I got like all of them wrong last year, but who cares
The estimated hazard ratio for time to first MACE was 0.86 (95% CI: 0.77, 0.96) over the median follow-up duration of 49.6 months and 49.4 months for patients randomized to RYBELSUS and placebo, respectively
This page is research-only and provides no dosing, administration, clinical, diagnostic, therapeutic, veterinary, cosmetic-use, or human-use guidance
[1] [2] When changing your weekly injection day, ensure at least 72 hours (3 days) between doses
Butler J, Shah SJ, Petrie MC et al (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials